Welcome to LookChem.com Sign In|Join Free
  • or
stephanthrine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

22108-99-2

Post Buying Request

22108-99-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22108-99-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 22108-99-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,0 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 22108-99:
(7*2)+(6*2)+(5*1)+(4*0)+(3*8)+(2*9)+(1*9)=82
82 % 10 = 2
So 22108-99-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H19NO2/c1-20(2)10-9-14-11-17-19(22-12-21-17)18-15-6-4-3-5-13(15)7-8-16(14)18/h3-8,11H,9-10,12H2,1-2H3

22108-99-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name stephenanthrine

1.2 Other means of identification

Product number -
Other names Des-N-methyl-aporphin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22108-99-2 SDS

22108-99-2Downstream Products

22108-99-2Relevant academic research and scientific papers

PHENANTHRENE DERIVATIVES FOR USE AS MEDICAMENTS

-

, (2016/08/07)

The present invention refers to phenanthrene derivatives for use as medicaments, mainly in the prevention and/or treatment of Myotonic Dystrophy Type 1, Huntington's Disease Like 2, Spinocerebellar Ataxia Type 8, Myotonic Dystrophy Type 2, Spinocerebellar Ataxia Type 3, Fragile-X-Associated Tremor/Ataxia Syndrome, Frontotemporal Degeneration/Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia Type 31. In a preferred embodiment, phenanthrene derivatives of the invention are also used as antimyotonic agents. Therefore, this invention may be included either in the whole pharmaceutical or medical field.

HOFMANN ELIMINATION WITH DIAZOMETHANE ON QUATERNARY BENZYLTETRAHYDROISOQUINOLINE RELATED ALKALOIDS

Lu, Sheng-Teh,Tsai, Ian-Lih

, p. 751 - 768 (2007/10/02)

The investigation have been made to the reaction of a large excess of diazomethane on the quaternary benzyltetrahydroisoquinoline related alkaloids, aporphines, benzyltetrahydroisoquinolines, pavines and protopine.From the structural elucidation of the reaction products, it has been found that the first and second Hofmann elimination proceeded.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 22108-99-2